HUCOP Clinical Pharmacy Rounds: L-Glutamine Use in Sickle Cell Disease


Date: Jun 4, 2019 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Jun 15, 2019 10:30 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacists
Students
Fellows
Residents
Faculty

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Registration Closed  

Objectives

  • Describe the pathophysiologyof sickle cell disease, its genotypic/phenotypic expression, complications and its prevalence in the United States
  • List current non-pharmacological and pharmacological treatment modalities
  • Outline L-Glutamine as a new FDA approved treatment for sickle cell disease, its safety, efficacy and administration
  • Explain the place in therapy of L-Glutamine in current treatment guidelines and its implications

Speaker(s)/Author(s)

Dr. Akosu Owusu-Dommey, PharmD
PGY-1 Resident

Activity Number

0010-9999-19-021-L01-P
Date: 06/04/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
Registration Closed